DATA GRAPHICS | Data Byte
The oncolytic virus pipeline
At least 49 oncolytic virus therapies now in development behind the sole FDA-approved product
November 16, 2021 2:40 AM UTC
Though oncolytic viruses have yet to deliver on their promise to revolutionize oncology, despite decades of attempts, development activity is on the rise and could be nearing a critical mass needed to finally start to turn a corner.
At least 46 companies have oncolytic virus programs in their pipelines, with a total a 49 disclosed therapies among them, according to an analysis by BioCentury. ...